Matthew Osborne

Title: Matthew Osborne: Innovator in Chemical Compounds

Introduction

Matthew Osborne is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemical compounds, holding a total of 3 patents. His work focuses on the development of pharmaceutical compositions and their applications in treating various disorders.

Latest Patents

Matthew's latest patents involve innovative chemical compounds. The first patent concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R to R have specific meanings defined in the description. This invention also includes processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of cell proliferative disorders. The second patent mirrors the first, emphasizing the same compounds and their therapeutic applications.

Career Highlights

Matthew Osborne is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Matthew has collaborated with esteemed colleagues, including Robert Hugh Bradbury and David Buttar. These partnerships have fostered innovation and enhanced the impact of their collective research efforts.

Conclusion

Matthew Osborne's contributions to the field of chemical compounds and his collaborations with other professionals highlight his importance as an inventor. His work continues to influence the pharmaceutical landscape, paving the way for advancements in medical treatments.